Marked tumor response and fatal hemoptysis during radiation for lung cancer in a human immunodeficiency virus-positive patient taking nelfinavir.
Chapman
Christopher H
CH
Department of Radiation Oncology, Stanford University, Stanford, California 94305, USA.
Shen
John
J
Filion
Edith J
EJ
Tran
Phuoc T
PT
Hara
Wendy
W
Asuncion
Alfredo
A
Marko
Daniel
D
Wakelee
Heather
H
Berry
Gerald J
GJ
Dimmick
Kevin W
KW
Loo
Billy W
BW
Green
Jon
J
D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000532:radiotherapy*; D017809:Fatal Outcome; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006679:HIV Seropositivity; D015497:HIV-1 / Q000472:pathogenicity*; D006469:Hemoptysis / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000209:etiology / Q000532:radiotherapy*; D008297:Male; D019888:Nelfinavir / Q000627:therapeutic use*
D017320:HIV Protease Inhibitors; D019888:Nelfinavir